Future development of pharmaceutical equipment machinery industry

Starting from the actual situation in China, we will implement a safe market access system for dryer quality. An important measure taken to ensure the quality of medicines. Shi Qing explained that the implementation of the safe market access system for pharmaceutical equipment quality is the need to improve the quality of pharmaceutical production, standardize the pharmaceutical equipment market, ensure the safety and health of consumers, and promote the healthy development of the industry. Medicine is a special commodity, life is a matter of life, zui is directly related to every family in the whole society, every consumer's physical health and life safety. Any kind of medicine or any kind of advanced pharmaceutical technology must be realized through pharmaceutical equipment. If the pharmaceutical equipment technology is backward, the quality is not in conformity with the "GMP requirements, even with advanced technology, excellent production environment, excellent operation. Managers, high-quality raw materials are also difficult to ensure the quality and safety of drugs. Therefore, in order to ensure the quality and safety of drugs, it is necessary to formulate a set of safety supervision system for pharmaceutical equipment that meets the requirements of the socialist market economy and operates effectively.
However, many enterprises are still in the stage of imitation, improvement and combination at the technical level. Although the national pharmaceutical equipment industry has achieved great results. Did not reach the level of innovation or more than the world's similar products. At this stage, the national pharmaceutical equipment is more than 10 years old compared with the level of foreign pharmaceutical equipment. The reasons for the slow development of China's pharmaceutical equipment technology are mainly due to the lack of composite talents in China's pharmaceutical equipment industry. Pharmaceutical equipment is a special specialty that integrates pharmaceutical technology, biotechnology, chemical machinery, machinery and manufacturing processes, acoustics, optics, automation control, and computer applications. The idea of ​​pharmaceutical equipment research and development is to carry out these related majors throughout the design process. Now, there are very few people who are engaged in the research and development of pharmaceutical equipment and can take care of two or three of them. It is difficult for a single professional to inject these into the research and development concept. Professional elements. Local pharmaceutical equipment companies are competing to suppress prices, which seriously affects the development of the industry.
Presented a zero down payment, payment after use, sales below the interest price, etc., now local pharmaceutical equipment companies stepped into the misunderstanding of competitive price sales. The low profit of the products has made the company's capital turnover difficult, and it is even less able to invest in technology development and innovation. It is beneficial to the healthy development of technological progress of enterprises and industries. Some enterprises have failed to ensure the quality of the whole machine and the after-sales service in order to reduce the cost, cut corners, and low-end configuration. Other drawbacks have reduced the international reputation of the country's pharmaceutical equipment. The parameter setting and change of the pharmaceutical equipment process route not only directly affect the quality and efficacy of the drug, but also directly affect the energy consumption, cost, economic benefits and the health of the operators. Since quite a number of pharmaceutical equipment manufacturers do not have the test conditions, it is difficult and difficult to find a good process route and high efficiency, so that the advanced potential of local pharmaceutical equipment cannot be effectively and effectively exerted. Experts pointed out that after the GMP certification, although the number of domestic pharmaceutical companies has decreased, the quality, production capacity and level, and product quality have been greatly improved, and the requirements for pharmaceutical machinery have also increased. Domestic pharmaceutical companies should give full play to their own advantages and strengthen their strength in pre-sales and after-sales services. Enterprises can cooperate with some pharmaceutical design institutes and research institutes to participate in drug development and process improvement of pharmaceutical companies, and win more customers by strengthening regular maintenance of equipment and training for customers. At the same time, enterprises should be good at seizing the opportunities of differentiation in the market and increase their technical strength to develop equipment suitable for the manufacture of traditional Chinese medicine.
The number of pharmaceutical equipment companies in the country is numerous and uneven. Can be foreseen, currently. With the gradual naivety and standardization of the pharmaceutical equipment market, the pharmaceutical equipment industry will face a major integration. In the increasingly fierce market competition, enterprises with small scale and no comparative advantage in product quality will be difficult to survive. Through mergers and acquisitions, leading enterprises in the industry will appear and occupy a considerable market share. Who can become the leader in the future pharmaceutical machinery industry? Undoubtedly those with high-tech innovative products. According to industry statistics, the sales volume of radical products in pharmaceutical equipment has been declining year by year, such as trough mixers, double cone mixers, etc., while the sales of high-tech pharmaceutical machinery products have steadily increased. Among similar products, automation equipment gradually replaces semi-automatic equipment, and advanced equipment gradually replaces backward equipment. The product technology level will become a key factor determining the market share of enterprises.